Last Mile Care
Last Mile Care focuses on delivering healthcare services directly to patients at home, aiming to bridge care gaps. These products often incorporate Remote Patient Monitoringand home visit teams to provide diagnostic services or ongoing care, enhancing accessibility and convenience for patients.
Product Usage: The VP of Operations uses Axle Health for coordinating schedules of patients, mobile resources, and remote clinicians, and also for optimizing routes considering drive times for their pediatrics organization.
Strengths: Axle Health is touted for its efficiency in matching up drive time in a mobile resource with a fixed remote resource, in-built NPS surveys and reporting features, user-friendly interface, cost-effectiveness, and flexibility in adding licenses.
Weaknesses: The VP pointed out that the current version of Axle Health assumes that bookings are made by patients leading to their clinicians needing to enter patient details manually each time, however, this issue seems to be getting addressed.
Overall Judgement: Despite minor workflow alignment issues, Axle Health has been beneficial for their work, providing high patient satisfaction, reliability, exceptional customer support and hence would be chosen again if given the opportunity.
Product Usage: Getlabs is primarily used by the company for home phlebotomy services, with an additional focus on improving laboratory test completion rates and enhancing patient convenience.
Strengths: Getlabs offers reasonable pricing, satisfactory geographic coverage, a consistently expanding service range, good collaboration and responsiveness, and employs W2 staff.
Weaknesses: Getlabs has limited coverage in rural areas, has shown weak interoperability and integration knowledge, and their white-label product is not fully customizable.
Overall Judgment: Despite mentioned weaknesses, the company is pleased with Getlabs’ services and believes it to be a strong player in the home phlebotomy market, owing to its focus on expansion and patient-oriented services.